GlassScriptPhysician profile
Evan M Schwechter
NPI 1659676740
$525.59
in general payments reported to CMS, 2019-2025
8 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.31 · 2020: $13.08 · 2021: $16.34 · 2022: $23.47 · 2023: $129 · 2024: $97.01 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $208.42 | 2025 | Mako |
| Nuvasive Specialized Orthopedics, INC. | $98.97 | 2023 | Precice Intramedullary Limb Lengthening System |
| Depuy Synthes Sales INC. | $68.30 | 2019-2023 | Reclaim, Actis |
| Bioventus LLC | $45.85 | 2020-2024 | Durolane |
| Convatec INC. | $39.01 | 2024 | |
| Janssen Biotech, INC. | $25.23 | 2024 | Tremfya |
| Csl Behring | $23.47 | 2022 | |
| Heraeus Medical, LLC. | $16.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Schwechter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.